91 results
Page 4 of 5
6-K
3f1kjmwd
30 Dec 19
Current report (foreign)
4:15pm
6-K
n5jza3y
14 Nov 19
Current report (foreign)
7:01am
6-K
EX-99.2
tlarhdrq2
1 Nov 19
Current report (foreign)
4:15pm
6-K
EX-99.1
vq2gu ak87air0i
1 Nov 19
Current report (foreign)
4:15pm
6-K/A
m55zfo
29 Aug 19
Current report (foreign) (amended)
5:25pm
6-K
kyzdk43
13 Aug 19
Current report (foreign)
7:00am
424B5
04oowzi78fnvykaxj1eq
17 May 19
Prospectus supplement for primary offering
5:19pm
6-K
6e3s8
15 May 19
Current report (foreign)
7:00am
6-K
1shl4i
18 Dec 18
Current report (foreign)
4:05pm
6-K
d4la tr5vm21
20 Nov 18
Current report (foreign)
7:00am
6-K
EX-99.1
m81r zj3c8600grpy6xx
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am
6-K
EX-99.2
tuzsoexpvcc pi
15 Oct 18
Notice of Annual General Meeting of Shareholders
8:15am
6-K
b61orwzc 8ybdum5j
16 Aug 18
Current report (foreign)
7:00am
424B5
v2h9o3xavwpebs5kok
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
EX-4.1
bpn5g55vfa
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am
6-K
EX-1.1
eu85 svaj1
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am